[Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct]
- PMID: 6163491
[Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct]
Abstract
Lidocaine (4--12 mg/kg) and the specific fast sodium current blocker tetrodotoxin (TTX) (1--6 mg/kg, i. v.) reduced ventricular arrhythmias that occurred 24 h after coronary artery ligation in dogs. Infusion of a mixture of subthreshold doses of lidocaine and TTX decreased ventricular arrhythmias to the same degree as infusion of threshold doses of either agent alone. This finding suggests that the antiarrhythmic action of lidocaine in the late stage of myocardial infarction is due to inhibition of the fast inward, sodium current. The possible mechanisms of rhythm disturbances in the late stage of myocardial infarction are discussed.
Similar articles
-
[Anti-arrhythmic effect of tetrodotoxin in the late stage of experimental myocardial infarct].Biull Eksp Biol Med. 1979 Oct;88(10):402-4. Biull Eksp Biol Med. 1979. PMID: 91393 Russian.
-
[Effect of tetrodotoxin and ethmozine on arrhythmias of a dog heart isolated in the late stage of experimental myocardial infarct].Biull Eksp Biol Med. 1980 Oct;90(10):446-8. Biull Eksp Biol Med. 1980. PMID: 6159013 Russian.
-
[Decrease in the fast sodium inflow current, a possible reason for the anti-arrhythmic action of etmozin and mexityl in the late stage of experimental myocardial infarct].Kardiologiia. 1980 May;20(5):19-22. Kardiologiia. 1980. PMID: 6156262 Russian.
-
Current understanding of lidocaine as an antiarrhythmic agent: a review.Clin Ther. 1984;6(2):125-41. Clin Ther. 1984. PMID: 6200230 Review.
-
CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels.Cardiovasc Drug Rev. 2006 Summer;24(2):101-15. doi: 10.1111/j.1527-3466.2006.00101.x. Cardiovasc Drug Rev. 2006. PMID: 16961724 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical